Clinical research on the effect of changing from denosumab to zoledronic acid (Multicenter collaborative retrospective observational research)
Not Applicable
- Conditions
- osteoporosis
- Registration Number
- JPRN-UMIN000037148
- Lead Sponsor
- Orthopedics Department, Shimura Hospital
- Brief Summary
either clinical vertebral fractures nor X-ray morphological new vertebral fractures occurred in 30 patients evaluated for fractures at 6 months and 12 months after ZOL administration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients undergoing treatment for malignancy (2) Patients with severe heart disease and cerebrovascular disease (3) Patients with serious diseases such as pancreas and blood (4) Patients with severe renal dysfunction or failure (for example, patients with eGFR (estimated glomerular filtration rate) less than 3.0 mL /min/1.73 m2, patients on dialysis) (5) In addition, patients that the research investigator or the doctor judged inappropriate for the target
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method